Back to Directory
TrophiCell
North West England
Founded 2023
Standardised mesenchymal stromal cell therapies for chronic tissue repair
TrophiCell develops cell therapies based on mesenchymal stromal cells, which release signals involved in tissue repair and immune regulation.
Its patented production method aims to generate standardised cells at scale from a single donor, addressing variability associated with earlier cell therapy approaches.
The company is targeting chronic conditions including osteoarthritis and liver disease, working with manufacturing and clinical partners to advance its therapeutic programmes.